LOADING

Paris at the reunion with international pneumology

Florin Dumitru Mihălțan

Between September 16-19, 2018, in Paris was held a new edition of the annual European Society of Pneumology Congress, under the slogan: “Help shape the future of respiratory science and medicine!” In an open competition with two other CHEST and ATS congresses, this meeting remains specific to Europe, with a remarkable openness to other continents. The onset was, as usual, with a day of pre-congress courses, numerous, on topics such as: asthma and COPD, imaging in pneumology, NIV – new challenges, emergency bronchoscopy, new diagnostic and therapeutic gains in lung cancer, interventional pneumol-ogy, mucoviscidosis – adult management,, etc. Concomitantly, joint events with bilingual symposiums with associations representing the main, international languages circulating in the world, such as SPLF, Society of Russian Pneumology, ALAT, Chinese Society of Pneumology,, etc., were held in the first day. The main topics of the congress covered three important areas – fundamental research, the clinical part, translational medicine – and the conditions approached were both high-frequency ones, such as COPD, bronchial asthma, lung cancer and bronchiectasis, but also rarer diseases, such as diffuse interstitial pneumonitis, mucoviscidosis,, etc.

rsp

There have been many subjects, with a roomful audi-ence, such as: phenotyping and endotyping in asthma, recent advances in ciliary dyskinesia, bronchiectasis, a new look at diagnosis and therapy, optimal therapy in pulmonary hypertension, fungal infections in intensive care units, pulmonary cancer immunotherapy, lung cancer screening for the solitary node. Different types of diagnostic interventions that have been dissected in terms of long-time use have been addressed. Topics such as: endo-scopic solutions in obstructive diseases, digital evolution in respiratory medicine, cryobiopsy in pulmonary fibrosis, clinical interpretations in spirometry, etc. made congress rooms insufficient. An interesting daily offer for congress participants was “Lung on Fire”, where complex clinical cases were extensively discussed by a group of experts and the audience. Likewise, practical workshops have proven that any presence of reputable specialists is beneficial for those present at the congress. Last but not least, the vot-ing system at each session, as well as the existence of a dialog with the audience at each session, made digitally, whether it was a symposium or a clinical case session, emerged as a new and interesting idea, stimulating effec-tively the audience. The international pneumological issues have not been avoided, and so the participants had the opportunity to get acquainted with the extensive knowledge they have gained over the past year in areas such as: lower respiratory tract infections and bacterial resistance; COPD and asthma – chronic noncommunicable diseases; the environment with climatic changes and res-piratory consequences; biologically targeted therapies in lung cancer; pulmonary interstitial diseases, etc. At the same time, they did not miss “State of the art – year in review”, focusing on topics like: the role of inflammation and bacteria in lung cancer; sleep and sleep disorders, progress in community pneumonia management; mechan-ical ventilation in acute or chronic respiratory failure, etc. Like at any congress, the pharmaceutical company sym-posiums were present, with multiple challenges related to the competition between bronchodilators in the dual bronchodilator therapy and the triple therapy of COPD. There are also worth mentioning, in this respect, other offers, such as: “Novelties in the nebulization treatment with inhaled corticosteroids” (Astra Zeneca), “Anti-IL5 – a therapeutic option in eosinophilic bronchial asthma” (GSK), “Priorities and preferences: the inhaler makes the difference in COPD” (Boehringer Ingelheim), “Bronchiectasis from guides to clinical practice” (Grifols), “Asthma patient’s day: what can we do?” (Novartis), “New dimensions in interventional pneumology” (Olympus), etc.

rspBut the Romanian presence and achievements were, in my opinion, exceptional in the premieres during this congress. Thus, the delegation consisted of over 120 pneu-mologists, and the number of communications and posters was 12. Apparently, nothing new. Traditionally, this con-gress is used constantly to reveal the progress in the Romanian pneumology since the last manifestation of such an important international event. The Romanian stand at “Village of Nations” was appreciated for its conci-sion and design, and the way the multitude of information was distributed. However, the premise was completely different – for the first time, a team of young enthusiasts (dr. Ana Nebunoiu, dr. Valentin Coșei, dr. Andrei Leșan) participated in a new competition of young clinicians with answers related to clinical cases, paraclinical results, etc. Concomitantly, for the first time in the Game Zone com-petition, there was a Romanian winner: dr. Petru Emil Muntean.

Paris, a city that makes the first steps towards reduc-ing urban pollution, was a welcoming host for over 22,000 pneumologists. At the border between summer and autumn, the city offered to congress participants a good visiting day in their time off, with famous historical monuments, mentioned in many international guides, but also unique occasions of delight with delicates-sen of the well-known French cuisine.

 

© Copyright 1993-2017 Societatea Romana de Pneumologie. All Rights Reserved.